Astrana Health Stock Performance

ASTH Stock   19.86  0.09  0.46%   
The firm shows a Beta (market volatility) of 2.3, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Astrana Health will likely underperform. At this point, Astrana Health has a negative expected return of -0.12%. Please make sure to confirm Astrana Health's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Astrana Health performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Astrana Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders. ...more

Actual Historical Performance (%)

One Day Return
0.46
Five Day Return
7.53
Year To Date Return
(21.25)
Ten Year Return
261.09
All Time Return
111.28
Last Split Factor
1:10
Last Split Date
2015-04-27
1
Disposition of 29502 shares by Lam Thomas S. of Astrana Health at 17.78 subject to Rule 16b-3
12/08/2025
2
Disposition of 25866 shares by Lam Thomas S. of Astrana Health at 22.0 subject to Rule 16b-3
12/10/2025
3
Astrana Health Valuation Check After Needhams New Buy Rating on Its ValueBased Care Strategy
12/16/2025
4
Disposition of 5102 shares by Kumar Dinesh M. of Astrana Health at 24.81 subject to Rule 16b-3
12/31/2025
5
Disposition of 3565 shares by Chiang John of Astrana Health at 47.35 subject to Rule 16b-3
01/02/2026
6
Disposition of 20000 shares by Schmidt David of Astrana Health at 5.79 subject to Rule 16b-3
01/13/2026
7
Will Astrana Healths 16-Market Expansion Refocus Its Value-Based Care Strategy Narrative
01/15/2026
8
Disposition of 1515 shares by Chiang John of Astrana Health at 18.41 subject to Rule 16b-3
01/22/2026
9
Disposition of 10759 shares by Kumar Dinesh M. of Astrana Health at 27.16 subject to Rule 16b-3
01/23/2026
10
Disposition of 1656 shares by Kumar Dinesh M. of Astrana Health at 25.06 subject to Rule 16b-3
01/27/2026
11
A Look At Astrana Healths Valuation After CMS Medicare Advantage Payment Proposal
01/29/2026
12
Disposition of 21334 shares by Brandon Sim of Astrana Health at 23.24 subject to Rule 16b-3
02/02/2026
13
Astrana Health Buy, Sell, or Hold Post Q3 Earnings
02/05/2026
14
Astrana Health Downgraded to Strong Sell Rating by Zacks Research
02/12/2026
15
Inspire Medical Systems, Astrana Health, Evolent Health, Corcept, and Centene Stocks Trade Up, What You Need To Know - Yahoo Finance Canada
02/13/2026
16
Astrana Health Inc. Stock Analysis Exploring A Massive 89.92 percent Potential Upside - DirectorsTalk Interviews
02/17/2026
Begin Period Cash Flow294.2 M
Total Cashflows From Investing Activities-192.4 M

Astrana Health Relative Risk vs. Return Landscape

If you would invest  2,260  in Astrana Health on November 23, 2025 and sell it today you would lose (274.00) from holding Astrana Health or give up 12.12% of portfolio value over 90 days. Astrana Health is currently does not generate positive expected returns and assumes 4.2972% risk (volatility on return distribution) over the 90 days horizon. In different words, 38% of stocks are less volatile than Astrana, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Astrana Health is expected to under-perform the market. In addition to that, the company is 5.76 times more volatile than its market benchmark. It trades about -0.03 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.15 per unit of volatility.

Astrana Health Target Price Odds to finish over Current Price

The tendency of Astrana Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 19.86 90 days 19.86 
about 89.25
Based on a normal probability distribution, the odds of Astrana Health to move above the current price in 90 days from now is about 89.25 (This Astrana Health probability density function shows the probability of Astrana Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.3 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Astrana Health will likely underperform. Additionally Astrana Health has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Astrana Health Price Density   
       Price  

Predictive Modules for Astrana Health

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Astrana Health. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Astrana Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
15.6119.9124.21
Details
Intrinsic
Valuation
LowRealHigh
18.9623.2627.56
Details
Naive
Forecast
LowNextHigh
17.8122.1126.41
Details
12 Analysts
Consensus
LowTargetHigh
32.4635.6739.59
Details

Astrana Health Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Astrana Health is not an exception. The market had few large corrections towards the Astrana Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Astrana Health, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Astrana Health within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.19
β
Beta against Dow Jones2.30
σ
Overall volatility
2.79
Ir
Information ratio -0.02

Astrana Health Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Astrana Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Astrana Health can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Astrana Health generated a negative expected return over the last 90 days
Astrana Health has high historical volatility and very poor performance
Astrana Health is unlikely to experience financial distress in the next 2 years
About 60.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Omnicell Inc Trading 3.26 percent Higher on Feb 20 - GuruFocus

Astrana Health Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Astrana Stock often depends not only on the future outlook of the current and potential Astrana Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Astrana Health's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding48.2 M
Cash And Short Term Investments290.8 M

Astrana Health Fundamentals Growth

Astrana Stock prices reflect investors' perceptions of the future prospects and financial health of Astrana Health, and Astrana Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Astrana Stock performance.

About Astrana Health Performance

By evaluating Astrana Health's fundamental ratios, stakeholders can gain valuable insights into Astrana Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Astrana Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Astrana Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.05  0.05 
Return On Capital Employed 0.08  0.09 
Return On Assets 0.03  0.03 
Return On Equity 0.05  0.06 

Things to note about Astrana Health performance evaluation

Checking the ongoing alerts about Astrana Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Astrana Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Astrana Health generated a negative expected return over the last 90 days
Astrana Health has high historical volatility and very poor performance
Astrana Health is unlikely to experience financial distress in the next 2 years
About 60.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Omnicell Inc Trading 3.26 percent Higher on Feb 20 - GuruFocus
Evaluating Astrana Health's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Astrana Health's stock performance include:
  • Analyzing Astrana Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Astrana Health's stock is overvalued or undervalued compared to its peers.
  • Examining Astrana Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Astrana Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Astrana Health's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Astrana Health's stock. These opinions can provide insight into Astrana Health's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Astrana Health's stock performance is not an exact science, and many factors can impact Astrana Health's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Astrana Stock analysis

When running Astrana Health's price analysis, check to measure Astrana Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astrana Health is operating at the current time. Most of Astrana Health's value examination focuses on studying past and present price action to predict the probability of Astrana Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astrana Health's price. Additionally, you may evaluate how the addition of Astrana Health to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios